Richard Hague

Richard Hague

Amministratore Delegato presso
PolarityTE MD, Inc.
65 anni
Health Technology
Consumer Services

Profilo

Richard Hague is currently Chief Executive Officer at PolarityTE MD, Inc. Formerly, Mr. Hague was President, Chief Executive Officer & Director at RegenETP, Inc. from 2023 to 2025.
Mr. Hague was Chief Commercial Officer at Anika Therapeutics, Inc. from 2015 to 2019.
Mr. Hague served as Vice President-Sales & Marketing at TEI Medical, Inc. from 2004 to 2015.
Mr. Hague was VP-Sales, Marketing & Commercial Operations at Sanofi UK from 2011 to 2014.
Mr. Hague was Senior Director at Genzyme Biosurgery Corp.
from 2001 to 2005.
Mr. Hague completed undergraduate studies at the University of Connecticut.

Posizioni attive di Richard Hague

SocietàPosizioneInizio
Amministratore Delegato -

Precedenti posizioni note di Richard Hague

SocietàPosizioneFine
REGENETP, INC. Amministratore Delegato 01/02/2025
ANIKA THERAPEUTICS, INC. Corporate Officer/Principal 05/04/2019
Vendite & Marketing 01/10/2015
Vendite & Marketing 01/01/2014
Direttore/Membro del Consiglio 01/01/2005
Vedi nel dettaglio l'esperienza di Richard Hague

Formazione di Richard Hague

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

41

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Richard Hague